Comparison of the basic demography, gestational history and pregnancy outcome of pregnant women in the blood glucose control effective group and ineffective group.

Comparison of the basic demography, gestational history and pregnancy outcome of pregnant women in the blood glucose control effective group and ineffective group.</p

Comparison of OGTT before MNT in the blood glucose control effective group and the ineffective group.

Comparison of OGTT before MNT in the blood glucose control effective group and the ineffective group.</p

Lamellar Oxygen-Enriched Graphene Hydrogel with Linking-up Network Porous Structure for High-Performance Supercapacitors

Here, we report a lamellar holey oxygen-enriched graphene hydrogel (LGH) consisting of graphene sheets with a large amount of oxygen functional groups and in-plane pores and confirm its excellent supercapacitive performances. LGH is quite different from the traditional graphene hydrogel in terms of both the morphology and porous structure. Importantly, the in-plane pores on the graphene sheets link up the out-of-plane interval between the graphene sheets to form a linking-up network porous structure. The in-plane pores result in more micropores and the additional oxygen functional groups on graphene sheets. The LGH single electrode exhibits an ultrahigh capacitance (337.8 F g^–1 at 1 A g^–1) and excellent rate capability (the specific capacitance at 100 A g^–1 retains 77% relative to 1 A g^–1). The asymmetric supercapacitor is assembled by using the LGH as positive electrode material and the graphene hydrogel that has adsorbed anthraquinone as negative electrode material, respectively. The device exhibits a high energy storage (energy density of 31.5 Wh kg^–1 along with power density of 0.9 kW kg^–1)

Comparison of different species enriched in effective groups and ineffective groups.

Comparison of different species enriched in effective groups and ineffective groups.</p

Changes in the gut microbiome of the effective group before and after MNT.

(a) Alpha diversity between the effective group before and after therapy; (b) Beta diversity between the effective group before and after therapy: Weighted Unifrac distance.</p

The results of LEfSe (LDA Effect Size) between the effective group and the ineffective group before the therapy.

(a) The evolutionary branching graph showed the differences in species richness between the two groups, the circle radiating from inside to outside in the figure represents the taxonomic level from phylum to genus. The species with significant differences are colored with the group. The green node indicates the microbial groups that play an important role in the effective group, and the blue node indicates the microbial groups that play an important role in the ineffective group. (b) The histogram of the distribution of LDA values mainly shows species with significantly different LDA scores greater than a predetermined value, i.e. biomarkers that are statistically different between the effective and ineffective groups before MNT.</p

The alpha diversity and beta diversity for the effective group and ineffective group before the therapy.

(a) Alpha diversity between the effective group and the ineffective group before the therapy; (b) Beta diversity between the effective group and the ineffective group before the therapy: Weighted Unifrac distance.</p

Comparison of glycemic results after MNT in the blood glucose control effective group and the ineffective group.

Comparison of glycemic results after MNT in the blood glucose control effective group and the ineffective group.</p

Comparison of gut microbiome in pregnant women with GDM after MNT.

(a). Alpha diversity between the effective group and the ineffective group after the therapy; beta diversity between the effective group and the ineffective group after the therapy: Weighted Unifrac distance; (b-c). LEfSe outcome between the effective group and the ineffective group after the therapy.</p

Changes in the gut microbiome of the ineffective group before and after MNT.

(a) Alpha diversity between the ineffective group before and after therapy; (b) Beta diversity between N1 and N2 group: Weighted Unifrac distance; (c) Results of linear discriminant analysis of gut microbiome before and after therapy outcome between effective group before and after therapy.</p